EcoDrugPlus

Platelet Derived Growth Factor Receptor Alpha

Ensembl ID : ENSHCOG00000015380
Gene Symbol: PDGFRA
3 Cross references
204 Possible Orthologues:

Platelet Derived Growth Factor Receptor Beta

Ensembl ID : ENSHCOG00000016508
Gene Symbol: PDGFRB
3 Cross references
198 Possible Orthologues:

Platelet Derived Growth Factor Subunit B

Ensembl ID : ENSHCOG00000006777
Gene Symbol: PDGFB
1 Cross references
196 Possible Orthologues:

Polo Like Kinase 1

Ensembl ID : ENSHCOG00000011376
Gene Symbol: PLK1
4 Cross references
188 Possible Orthologues:

Polo Like Kinase 4

Ensembl ID : ENSHCOG00000020214
Gene Symbol: PLK4
3 Cross references
215 Possible Orthologues:

Poly [Adp-Ribose] Polymerase 3-Like

Ensembl ID : ENSHCOG00000004741
Gene Symbol: LOC109522412
3 Cross references
196 Possible Orthologues:

Poly [Adp-Ribose] Polymerase 3-Like

Ensembl ID : ENSHCOG00000004731
Gene Symbol: LOC109522167
3 Cross references
196 Possible Orthologues:

Poly(Adp-Ribose) Polymerase 1

Ensembl ID : ENSHCOG00000011619
Gene Symbol: PARP1
3 Cross references
209 Possible Orthologues:

Poly(Adp-Ribose) Polymerase 2

Ensembl ID : ENSHCOG00000012275
Gene Symbol: PARP2
3 Cross references
185 Possible Orthologues:

Porcupine O-Acyltransferase

Ensembl ID : ENSHCOG00000009812
Gene Symbol: PORCN
3 Cross references
193 Possible Orthologues:

Potassium Calcium-Activated Channel Subfamily M Alpha 1

Ensembl ID : ENSHCOG00000002653
Gene Symbol: KCNMA1
3 Cross references
85 Possible Orthologues:

Potassium Calcium-Activated Channel Subfamily M Alpha 1

Ensembl ID : ENSHCOG00000001274
Gene Symbol: KCNMA1
3 Cross references
92 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).